• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性血管疾病、脉压与死亡率。

Polyvascular disease, pulse pressure and mortality.

机构信息

Fifth Department of Medicine, Faculty of Medicine of the University of Heidelberg, University Medical Center Mannheim UMM, Mannheim, Germany.

SYNLAB MVZ Humangenetik Mannheim, Germany.

出版信息

Vasa. 2022 Jul;51(4):229-238. doi: 10.1024/0301-1526/a001011. Epub 2022 May 23.

DOI:10.1024/0301-1526/a001011
PMID:35603601
Abstract

Peripheral arterial disease (PAD), coronary artery disease (CAD) and carotid stenosis (CS) are robust predictors of mortality. The value of individual vascular beds in polyvascular disease (PVD) to predict mortality in patients with atherosclerotic burden is not clear. Therefore, we have examined the predictive value of PAD, CAD and CS in patients at intermediate to high risk of cardiovascular (CV) disease. In our retrospective observational study we analyzed baseline data from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study, a monocentric cohort study of 3316 patients referred to coronary angiography. As the number of atherosclerotic vascular beds increased, the hazard ratios (HRs) for both all-cause mortality and CV mortality significantly increased in a multivariate analysis after adjusting for age, sex, body mass index, diabetes mellitus and estimated glomerular filtration rate, with HRs of 1.36 (95%CI: 1.11-1.68), 2.56 (95%CI: 2.01-3.26), 2.84 (95%CI: 1.93-4.17) and 1.56 (95%CI: 1.19-2.06), 2.70 (95%CI: 1.97-3.72), 3.50 (95%CI: 2.19-5.62), respectively. The combination of PAD with either CAD or CS was associated with higher HRs for all-cause (HR 2.81 and 7.53, respectively) and CV (HRs 2.80 and 6.03, respectively) mortality compared with the combination of CAD and CS (HRs 1.94 and 2.43, respectively). The presence of PVD was associated with higher age, systolic blood pressure, pulse pressure (PP; a marker of vascular stiffness), former smoking and inversely with lower eGFR. We show that as the number of atherosclerotic vascular beds increases, all-cause and CV mortality rates increase in parallel. Simultaneous prevalence of PAD is associated with significantly higher all-cause and CV mortality rates compared with CS coexistence. Furthermore, increasing atherosclerotic load may contribute to vascular stiffness and impaired renal function.

摘要

外周动脉疾病(PAD)、冠状动脉疾病(CAD)和颈动脉狭窄(CS)是死亡率的有力预测因素。在动脉粥样硬化负担患者中,单个血管床在多血管疾病(PVD)中的价值来预测死亡率尚不清楚。因此,我们检查了 PAD、CAD 和 CS 在心血管疾病(CV)中危至高危患者中的预测价值。 在我们的回顾性观察研究中,我们分析了来自路德维希港风险和心血管健康(LURIC)研究的基线数据,这是一项针对 3316 例接受冠状动脉造影的患者的单中心队列研究。 在多变量分析中,随着动脉粥样硬化血管床数量的增加,全因死亡率和 CV 死亡率的危险比(HR)在调整年龄、性别、体重指数、糖尿病和估计肾小球滤过率后显著增加,HR 分别为 1.36(95%CI:1.11-1.68)、2.56(95%CI:2.01-3.26)、2.84(95%CI:1.93-4.17)和 1.56(95%CI:1.19-2.06)、2.70(95%CI:1.97-3.72)、3.50(95%CI:2.19-5.62)。PAD 与 CAD 或 CS 的组合与全因(HR 2.81 和 7.53)和 CV(HR 2.80 和 6.03)死亡率相关,与 CAD 和 CS(HR 1.94 和 2.43)的组合相比,死亡率更高。PVD 的存在与更高的年龄、收缩压、脉搏压(PP;血管僵硬的标志物)、以前吸烟有关,与较低的 eGFR 呈反比。 我们表明,随着动脉粥样硬化血管床数量的增加,全因和 CV 死亡率呈平行增加。PAD 的同时患病率与 CS 共存相比,与全因和 CV 死亡率显著升高相关。此外,动脉粥样硬化负荷的增加可能导致血管僵硬和肾功能受损。

相似文献

1
Polyvascular disease, pulse pressure and mortality.多发性血管疾病、脉压与死亡率。
Vasa. 2022 Jul;51(4):229-238. doi: 10.1024/0301-1526/a001011. Epub 2022 May 23.
2
Association of double product and pulse pressure with cardiovascular and all-cause mortality in the LURIC study.LURIC研究中双倍乘积与脉压与心血管及全因死亡率的关联
J Clin Hypertens (Greenwich). 2020 Dec;22(12):2332-2342. doi: 10.1111/jch.14067. Epub 2020 Oct 9.
3
Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease. Rho-kinase 活性升高可作为伴有冠状动脉和外周动脉疾病的多血管疾病患者动脉粥样硬化和炎症负担的标志物。
Clin Cardiol. 2013 Jun;36(6):347-51. doi: 10.1002/clc.22118. Epub 2013 Mar 28.
4
Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease.冠心病患者颈动脉疾病、肾动脉狭窄和下肢外周动脉疾病共存。
Am J Cardiol. 2014 Jan 1;113(1):30-5. doi: 10.1016/j.amjcard.2013.09.015. Epub 2013 Oct 3.
5
The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients.多血管疾病对经皮冠状动脉介入治疗患者长期预后的影响。
Eur J Clin Invest. 2014;44(3):231-9. doi: 10.1111/eci.12222. Epub 2013 Dec 27.
6
Impact of preexisting coronary artery and peripheral artery disease on outcomes in diabetic patients after kidney transplant.糖尿病患者肾移植术后预先存在的冠状动脉和外周动脉疾病对结局的影响。
Vasc Med. 2024 Apr;29(2):135-142. doi: 10.1177/1358863X231205574. Epub 2023 Nov 7.
7
Polyvascular extracoronary atherosclerotic disease in patients with coronary artery disease.冠状动脉疾病患者的冠状动脉外多血管粥样硬化性疾病。
Kardiol Pol. 2009 Aug;67(8A):978-84.
8
Patients with Polyvascular Disease: A Very High-risk Group.多血管疾病患者:极高危人群。
Curr Vasc Pharmacol. 2022;20(6):475-490. doi: 10.2174/1570161120666220912103321.
9
Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index.用杜克活动状态指数评估的基线功能能力预测稳定型外周动脉疾病的长期预后。
Am Heart J. 2017 Feb;184:17-25. doi: 10.1016/j.ahj.2016.10.009. Epub 2016 Oct 20.
10
Prediction of coronary artery disease in patients with lower extremity peripheral artery disease.下肢外周动脉疾病患者冠状动脉疾病的预测
Int Heart J. 2015;56(2):209-12. doi: 10.1536/ihj.14-284. Epub 2015 Feb 27.

引用本文的文献

1
Inflammation, Lp(a) and cardiovascular mortality: results from the LURIC study.炎症、脂蛋白(a)与心血管死亡率:LURIC研究结果
Clin Res Cardiol. 2025 Feb 6. doi: 10.1007/s00392-025-02609-4.
2
Association between Arterial Stiffness, Carbamylation, and Mortality in Patients Undergoing Coronary Angiography with No or Mild Chronic Kidney Disease.无或轻度慢性肾脏病的冠状动脉造影患者动脉僵硬度、氨基甲酰化与死亡率之间的关联
Cardiorenal Med. 2025;15(1):83-97. doi: 10.1159/000543143. Epub 2024 Dec 19.
3
Relationship between rs1410996 polymorphism of CFH gene and essential hypertension patients of Han from Yunnan Province.
CFH 基因 rs1410996 多态性与云南汉族原发性高血压的相关性研究。
Mol Biol Rep. 2024 Aug 6;51(1):888. doi: 10.1007/s11033-024-09819-5.
4
Current Management of Peripheral Artery Disease: Focus on Pharmacotherapy.当前外周动脉疾病的管理:聚焦于药物治疗。
Drugs. 2022 Jul;82(11):1165-1177. doi: 10.1007/s40265-022-01755-7. Epub 2022 Aug 12.